Enedra Therapeutics Ltd

About

Enedra is a biotech company targeting cancer’s ability to evolve and develop treatment resistance. Their platform, called CASPAROV, identifies the key mechanisms that allow tumors to survive chromosomal instability, a major driver of cancer evolution. Enedra can then develop drugs that disrupt those crucial survival mechanisms while also identifying biomarkers to select the patients most likely to respond.